Evofem Biosciences
EVFM • OTC
Evofem Biosciences is a biotechnology company in the healthcare sector trading on OTC, led by CEO Saundra Pelletier.
CEOSaundra Pelletier
Biotechnology
Healthcare
Next Earnings
Upcoming earnings announcement for Evofem Biosciences
Date
Thursday, May 14, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
Earnings History
Past 12 earnings reports for Evofem Biosciences
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 11, 2026 | Q4 2025 | $0.00 | — | $9.6M | — | — |
| Nov 13, 2025 | Q3 2025 | -$0.01 | — | $5.0M | — | — |
| Aug 14, 2025 | Q2 2025 | -$0.02 | — | $4.8M | — | — |
| May 15, 2025 | Q1 2025 | $0.00 | — | $845.0K | — | — |
| Mar 24, 2025 | Q4 2024 | -$0.03 | — | $7.1M | — | — |
| Nov 14, 2024 | Q3 2024 | -$0.02 | — | $4.5M | — | — |
| Aug 14, 2024 | Q2 2024 | $0.00 | — | $4.2M | — | — |
| May 15, 2024 | Q1 2024 | -$0.16 | — | $3.6M | — | — |
| Mar 27, 2024 | Q4 2023 | -$0.44 | — | $4.8M | — | — |
| Nov 14, 2023 | Q3 2023 | $0.10 | — | $5.1M | — | — |
| Aug 14, 2023 | Q2 2023 | -$5.43 | — | $2.5M | — | — |
| Jun 16, 2023 | Q1 2023 | -$1.85 | — | $5.8MEst: $13.5M | -57.0% | — |